References
van den Hurk CJG, Eckel R, van de Poll-Franse LV et al (2011) Unfavourable pattern of metastases in M0 breast cancer patients during 1978–2008: a population based analysis of the Munich Cancer Registry. Breast Cancer Res Treat. doi:10.1007/s10549-011-1372-y
Coleman MP, Forman D, Bryant H et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. The Lancet 377:127–138
Chu KC, Tarone RE, Kessler LG et al (1996) Recent trends in US breast cancer incidence, survival and mortality rate. J Natl Cancer Inst 88:1571–1579
Peto R, Boreham J, Clarke M et al (2000) UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years. Lancet 355:1822
Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752
Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomized trials. Lancet 365:1687–1717
Kennecke H, Yerushalmi R, Woods R et al (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271–3277
Hess KR, Pusztai L, Buzdar AU et al (2003) Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Res Treat 78:105–118
Gaedcke J, Traub F, Milde S et al (2007) Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol 20:864–870
Smid M, Wang Y, Zhang Y et al (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68:3108–3114
Chia SK, Speers CH, D’yachkova Y et al (2007) The impact of new chemotherapeutic and hormonal agents on survival in a population based cohort of women with metastatic breast cancer. Cancer 110:973–979
Giordano SH, Buzdar AU, Smith TL et al (2004) Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000. Cancer 100:44–52
Arveux P, Grosclaude P, Reyrat E et al (2003) Breast cancer survival in France: a relative survival analysis based on 68,449 cases treated in the 20 French comprehensive cancer centres between 1980 and 1999. Proc Am Soc Clin Oncol 22:3437a
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an invited commentary to article doi: 10.1007/s10549-011-1372-y.
Rights and permissions
About this article
Cite this article
Chia, S. Trends in improving survival in breast cancer: two steps forward but one step back?. Breast Cancer Res Treat 128, 807–809 (2011). https://doi.org/10.1007/s10549-011-1490-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1490-6